Why is the Nagoya Protocol important? The Nagoya Protocol will create greater legal certainty and transparency for both providers and users of genetic resources by: Establishing more predictable conditions for access to genetic resources.
What is access and benefit sharing ABS in relation to the Convention on Biological Diversity?
Access and benefit-sharing (ABS) refers to the way in which genetic resources may be accessed, and how the benefits that result from their use are shared between the people or countries using the resources (users) and the people or countries that provide them (providers).
What is benefit sharing mechanism?
benefits are distributed through a community benefit-sharing mechanism (CBSM) and entail the transforming of funds from forest resources into fair and equitably allocated benefits with additional and permanent outcomes for communities.
What is benefit sharing under Biodiversity Act?
Benefit Sharing – Equitable sharing of the benefits (both monetary and non-monetary), arising out of the use of accessed biological resources, their by-products, innovations and practices associated with their use and applications and knowledge relating thereto in accordance with mutually agreed terms and conditions …
What is the importance of Cartagena Protocol on Biosafety?
The Cartagena Protocol on Biosafety is a legally binding global protocol that seeks to contribute to ensuring the safe transfer, handling and use of living modified organisms (LMOs) created through modern biotechnology.
What is ABS clearing house?
The Access and Benefit-sharing Clearing-House (ABS Clearing-House, ABSCH) is a platform for exchanging information on access and benefit-sharing established by Article 14 of the Nagoya Protocol, as part of clearing-house mechanism under Article 18, paragraph 3 of the Convention.
Why is Cartagena Protocol for Biosafety important?
The Cartagena Protocol on Biosafety to the Convention on Biological Diversity is an international agreement which aims to ensure the safe handling, transport and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account …
